
Join to view full profile
1 Gustave L Levy PlNew York, NY 10029
Phone+1 212-241-1951
Fax+1 212-534-7491
Dr. Jaffer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Cytopathology, 1998 - 1999
Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 1997 - 1998
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Pathology-Anatomic and Clinical, 1993 - 1997
Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 1992 - 1993
Icahn School of Medicine at Mount SinaiClass of 1992
Certifications & Licensure
NY State Medical License 1994 - 2027
American Board of Pathology Anatomic Pathology & Clinical Pathology
American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Listed in top abstracts Anatomic Pathology by College of American Pathologists (CAP)., 2015
- Listed in Top Ten Breast Cancer Papers Annual meeting of the American Society of Breast Surgeons, 2008
- Nominated Best Intern of the year Long Island Jewish Medical Center, 1993
Publications & Presentations
PubMed
- Pathologic features and biomarker profiles of microinvasive breast carcinoma diagnosed on core needle biopsy with excision correlation.Elif Demirci, Aruuke Sulaimanova, Sifan Zou, Sabina Hajiyeva, Shabnam Jaffer
Virchows Archiv. 2026-10-01 - 11 citationsWorld Health Organization classification of tumours of the breast 6th edition 2026.Cecily Quinn, Puay Hoon Tan, Kimberly H Allison, Edi Brogi, Sunil R Lakhani
Histopathology. 2026-08-01 - A Comparative Analysis of HER2 Immunohistochemistry in Core Biopsy Versus Excision in the Era of HER2 ``Low'' Breast Cancers.Swati Bhardwaj, Shabnam Jaffer
Clinical Breast Cancer. 2026-03-01
Journal Articles
- Correlation of Oncotype DX recurrence score with histomorphology and immunohistochemistry in over 500 patientsHanna M, Bleiweiss IJ, Nayak A, Jaffer S., International Journal of Breast Cancer, 1/1/2017
- Is Atypical ductal hyperplasia diagnosed on needle biopsy of an imaging finding a risk factor for breast cancer?Menes TS, Kerlikowske K, Jaffer S, Seger D and Miglioretti DL, JAMA Oncol, 1/1/2017
- Close and positive lumpectomy margins are associated with similar rates of residual disease with additional surgeryFitzgerald S, Romanoff A, Cohen A, Schmidt H, Weltz C, Bleiwiess IJ, Jaffer S, Port E, Ann Surg Oncol., 1/1/2016
Books/Book Chapters
Abstracts/Posters
- Not All Ductal Carcinoma In Situ (DCIS) Are Created IDLE (Indolent Lesions of Epithelial Origin).Alexander M, Nayak A, Jaffer S, Mod Path, 1/1/2017
- A Systematic Method of Assessing ER/PR/Her2 on Core Biopsy and or Excision Specimens.Reindl B, Bleiweiss IJ, Nayak A, Jaffer S., Mod Path, 1/1/2016
- Intraductal Papillomas of the Breast on Core Biopsy, Re-Visiting 10 Years Experience with More Than 500 Cases.Reindl B, Bleiweiss IJ, Nayak A, Jaffer S., Mod Path, 1/1/2016
Lectures
- Not all Ductal Carcinoma in Situ (DCIS) are created IDLE (Indolent lesions of Epithelial Origin)1/1/2017
- Pathology Process from Biopsy to Report: Specimen Preparation, Slides & BiomarkersNational Consortium of Breast Centers (NCoBC), Las Vegas, NV - 1/1/2017
- Modern Classification of Breast Cancer.National Consortium of Breast Centers (NCoBC), Las Vegas, NV - 1/1/2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: